Go 6976 (10 µM) did not prevent Glt-1 clustering in LRRK2 G2019S astrocytes compared with LRRK2 G2019S controls. In HLMVEC cells stimulated with listeriolysin or pneumolysin, pretreatment with Go 6976 (1 µM) significantly decreased toxin-induced PKC-substrate phosphorylation compared with cells without the inhibitor. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Go 6976 did not prevent Glt-1 clustering
Cell-based study · LRRK2 G2019S astrocytes [1]
Go 6976 (10 µM) did not prevent Glt-1 clustering in LRRK2 G2019S astrocytes in the comparison of LRRK2 G2019S versus LRRK2 G2019S + Go 6976.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 µM
- Co-treatment
- Other interventions in this design: Flag-Glt-1. Compound effect isolated by the comparison: LRRK2 G2019S vs LRRK2 G2019S + Go 6976.
- Reported limits
- Not stated in the sentences used: route, schedule, vehicle.
Methods and source locations
Compound reported in the paper: Go 6976
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Pharmacological treatments (S145); Results > Glt-1 displays an altered localization in LRRK2 G2019S astrocytes (S238); Fig. 4 legend (S309, S311)
number of Glt-1-positive clusters per cell: number of Glt-1-positive clusters per cell; comparator: LRRK2 G2019S — Materials and methods > Pharmacological treatments (S145); Results > Glt-1 displays an altered localization in LRRK2 G2019S astrocytes (S238); Fig. 4 legend (S311)
PKC-Substrate Phosphorylation in Toxin-Stimulated HLMVEC Cells
Cell-based study · HLMVEC cells [2]
HLMVEC cells were pretreated with or without Go 6976 (1 µM) before stimulation with listeriolysin or pneumolysin. Both toxins increased PKC-substrate phosphorylation, which was significantly decreased by Go 6976.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 µM
- Exposure duration
- stimulated with listeriolysin (LLO, 60 ng/ml) or pneumolysin (PLY, 30 ng/ml) for 30 min.
- Method
- pretreated
- Co-treatment
- Other interventions in this design: listeriolysin 60 ng/ml. Compound effect isolated by the comparison: pretreated with or without the PKCα inhibitor (Go6976, 1 µM).
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Go 6976
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > G+-toxins stimulate PKCα and eNOS T495 phosphorylation (S42); Figure 3 legend (S75)
phosphorylation of PKC-substrates: phosphorylation of PKC-substrates; comparator: without the PKCα inhibitor (Go6976, 1 µM) — Results > G+-toxins stimulate PKCα and eNOS T495 phosphorylation (S42); Figure 3 legend (S75)